Simplex Trading
CTXR icon

Simplex Trading’s Citius Pharmaceuticals CTXR Stock Holding History

Simplex Trading’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-332
Closed -$4K – 8676
2024
Q3 		$4K Buy
+332
New +$5.59K ﹤0.01% 7696
2024
Q1 		– Sell
-1,528
Closed -$28K – 8994
2023
Q4 		$28K Hold
1,528
– – ﹤0.01% 6618
2023
Q3 		$26K Hold
1,528
– – ﹤0.01% 6382
2023
Q2 		$45K Sell
1,528
-16
-1% -$527 ﹤0.01% 5938
2023
Q1 		$45K Sell
1,544
-168
-10% -$4.84K ﹤0.01% 6032
2022
Q4 		$33K Buy
1,712
+144
+9% +$3.93K ﹤0.01% 6333
2022
Q3 		$47K Buy
1,568
+212
+16% +$5.83K ﹤0.01% 6527
2022
Q2 		$31K Buy
1,356
+104
+8% +$2.85K ﹤0.01% 7095
2022
Q1 		$56K Buy
+1,252
New +$49.4K ﹤0.01% 6980
2021
Q4 		– Sell
-1,368
Closed -$88K – 10602
2021
Q3 		$88K Buy
+1,368
New +$68.6K ﹤0.01% 6799

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM

Simplex Trading's CTXR Position: Q2 2026 in Review

Simplex Trading opened a new position in Citius Pharmaceuticals (CTXR) in Q2 2026: 1,256 shares worth $759. The stake represents ﹤0.01% of the portfolio and ranks #8883 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CTXR as recently as Q3 2025.

Simplex Trading first reported a position in CTXR in Q3 2021 and has held it in 13 quarters since. The position peaked at $62K in Q3 2021. 43 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

  • Simplex Trading held 1,256 shares of Citius Pharmaceuticals worth $759 as of Q2 2026.
  • Citius Pharmaceuticals was a new Simplex Trading position in Q2 2026.
  • Citius Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #8883 holding.
  • Simplex Trading first reported a position in Citius Pharmaceuticals in Q3 2021 and has held it in 13 quarters since.
  • Simplex Trading's Citius Pharmaceuticals position peaked at $62K in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.